Journal of International Psychiatry

Tardive dyskinesia(TD) is a disease that can seriously influence the living ability of patients. It’s a common adverse effect in the procedure of psychiatry dose take medicine. Since deutetrabenazine was used to cure tardive dyskinesia in 2017, this medicine was gradually used in clinical treatment. Conformation evidence gives a cue that this medicine has a good therapeutic effect and tolerance. This patient is a woman aged 66 who is diagnosed with “depressive disorder”. She has taken doxepin and perphenazine tablets for a long time and has the symptoms of numbness of limbs, involuntary twitch, and oral peristalsis. She was diagnosed as “TD” and had a bad effect after she took vitamin C and clonazepam. Later she had a good effect after taking deutetrabenazine tablets and the symptom was gradually worsening. This article will be used to provide reference and experience in the clinical work of psychiatry through this case report.

Movement disorders; Tardive Dyskinesia;Deutetrabenazine; Antipsychotic Agents;